Yunxiang C Liu

US Patent:

20200069575, Mar 5, 2020

Filed:

Aug 28, 2019

Appl. No.:

16/554134

Inventors:

Yunxiang LIU - San Diego CA, US
Eric LIU - Medford MA, US

International Classification:

A61K 9/00
A61K 31/137
A61K 47/34
A61K 31/222

Abstract:

Disclosed are ophthalmic formulations, processes for preparing the same and methods for treating and preventing oculopathy with the same.

US Patent:

20200069577, Mar 5, 2020

Filed:

Aug 28, 2019

Appl. No.:

16/554102

Inventors:

Yunxiang LIU - San Diego CA, US
Eric LIU - Medford MA, US

International Classification:

A61K 9/00
A61K 47/34
A61K 31/27
A61F 9/00

Abstract:

Disclosed are ophthalmic formulations, processes for preparing the same and methods for treating and preventing oculopathy with the same.

US Patent:

20200069696, Mar 5, 2020

Filed:

Aug 28, 2019

Appl. No.:

16/553739

Inventors:

Yunxiang LIU - San Diego CA, US

International Classification:

A61K 31/55
A61K 9/16
A61K 9/127
A61K 9/06
A61K 9/00
A61K 31/222
A61K 31/44

Abstract:

Disclosed are an ophthalmic injectable sustained-release formulation, a process for preparing the same and a method for treating and preventing oculopathy with the same. The ophthalmic injectable sustained-release formulation comprises a delivery system and a pharmaceutically acceptable excipient, wherein the delivery system is selected from the group consisting of microspheres, microcapsules, microparticles, liposomes, multivesicular liposomes, nanocrystals and nanoparticles.